The Proceedings of the American Thoracic Society 1:255-263 (2004)
© 2004 The American Thoracic Society
Post-transcriptional and Nongenomic Effects of Glucocorticoids
Cristiana Stellato
Division of Allergy and Clinical Immunology, The Johns Hopkins University, Baltimore, Maryland
Correspondence and requests for reprints should be addressed to Cristiana Stellato, M.D., Ph.D., Johns Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Room 1A.12A, Baltimore, MD 21224. E-mail: stellato{at}jhmi.edu
The ability of glucocorticoids to interfere with post-transcriptional gene regulation has recently been recognized as a potentially important part of their anti-inflammatory property, and the mechanisms governing such activity are under active investigation. Several studies have shown that glucocorticoids can inhibit inflammatory signaling pathways known to control mRNA turnover and translation. Moreover, several glucocorticoid-sensitive determinants have been identified on mRNA molecules of inflammatory genes, and the RNA-binding factors interacting with them might constitute relevant glucocorticoid targets. Glucocorticoids also exert effects characterized as nongenomic, which occur within minutes of drug administration. The mechanisms of action of nongenomic glucocorticoid effects differ from the classical, transcription-dependent glucocorticoid action and involve the production of second-messenger molecules and activation of signal transduction pathways, either by the nuclear glucocorticoid receptor or by a membrane glucocorticoid receptor that has not yet been fully characterized. Ultimately, the discovery of novel pathways involved in mediating the actions of glucocorticoids should lead to improved targets for anti-inflammatory therapy.
Key Words: glucocorticoid receptor mRNA stability RNA-binding protein
This article has been cited by other articles:

|
 |

|
 |
 
F. T. Ishmael, X. Fang, M. R. Galdiero, U. Atasoy, W. F. C. Rigby, M. Gorospe, C. Cheadle, and C. Stellato
Role of the RNA-Binding Protein Tristetraprolin in Glucocorticoid-Mediated Gene Regulation
J. Immunol.,
June 15, 2008;
180(12):
8342 - 8353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Gounarides, M. Korach-Andre, K. Killary, G. Argentieri, O. Turner, and D. Laurent
Effect of Dexamethasone on Glucose Tolerance and Fat Metabolism in a Diet-Induced Obesity Mouse Model
Endocrinology,
February 1, 2008;
149(2):
758 - 766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Li, Y. Li, Y. Li, H. Liu, Z. Sun, J. Lu, and Y. Zhao
Glucocorticoid repression of human with-no-lysine (K) kinase-4 gene expression is mediated by the negative response elements in the promoter
J. Mol. Endocrinol.,
January 1, 2008;
40(1):
3 - 12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Renda, S. Baraldo, G. Pelaia, E. Bazzan, G. Turato, A. Papi, P. Maestrelli, R. Maselli, A. Vatrella, L. M. Fabbri, et al.
Increased activation of p38 MAPK in COPD
Eur. Respir. J.,
January 1, 2008;
31(1):
62 - 69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Otulakowski, W. Duan, S. Gandhi, and H. O'Brodovich
Steroid and Oxygen Effects on eIF4F Complex, mTOR, and ENaC Translation in Fetal Lung Epithelia
Am. J. Respir. Cell Mol. Biol.,
October 1, 2007;
37(4):
457 - 466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Newton and N. S. Holden
Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor?
Mol. Pharmacol.,
October 1, 2007;
72(4):
799 - 809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Zhang, Q. A. Truong-Tran, B. Tancowny, K. E. Harris, and R. P. Schleimer
Glucocorticoids Enhance or Spare Innate Immunity: Effects in Airway Epithelium Are Mediated by CCAAT/Enhancer Binding Proteins
J. Immunol.,
July 1, 2007;
179(1):
578 - 589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Dhawan, B. Liu, B. C. Blaxall, and M. B. Taubman
A Novel Role for the Glucocorticoid Receptor in the Regulation of Monocyte Chemoattractant Protein-1 mRNA Stability
J. Biol. Chem.,
April 6, 2007;
282(14):
10146 - 10152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Shaw, K. Gabor, E. Hand, A. Lankowski, L. Durant, R. Thibodeau, C. R. Stanton, R. Barnaby, B. Coutermarsh, K. H. Karlson, et al.
Role of glucocorticoid receptor in acclimation of killifish (Fundulus heteroclitus) to seawater and effects of arsenic
Am J Physiol Regulatory Integrative Comp Physiol,
February 1, 2007;
292(2):
R1052 - R1060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Goldsmith, M. B. Hershenson, M. P. Wolbert, and J. K. Bentley
Regulation of airway smooth muscle {alpha}-actin expression by glucocorticoids
Am J Physiol Lung Cell Mol Physiol,
January 1, 2007;
292(1):
L99 - L106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Chivers, W. Gong, E. M. King, J. Seybold, J. C. Mak, L. E. Donnelly, N. S. Holden, and R. Newton
Analysis of the Dissociated Steroid RU24858 Does Not Exclude a Role for Inducible Genes in the Anti-Inflammatory Actions of Glucocorticoids
Mol. Pharmacol.,
December 1, 2006;
70(6):
2084 - 2095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, T. J. Nickola, N. L. DiFronzo, A. M. Colberg-Poley, and M. C. Rose
Dexamethasone-Mediated Repression of MUC5AC Gene Expression in Human Lung Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
March 1, 2006;
34(3):
338 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Horvath and A. Wanner
Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma
Eur. Respir. J.,
January 1, 2006;
27(1):
172 - 187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Fan, N. M. Heller, M. Gorospe, U. Atasoy, and C. Stellato
The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy
Eur. Respir. J.,
November 1, 2005;
26(5):
933 - 947.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Thoracic Society.
|
|
|